Tuesday, 17 Sep 2019

You are here

21st Century Cures Act Passes in the House

On Friday, July 10th, the U.S. House voted overwhelmingly to streamline the approval process of prescription drugs and medical devices by the FDA.

If passed in the Senate and signed by President Obama, the “21stCentury Cures Act” would foster significant regulatory changes in the introduction of new drugs to the market. The legislation passed 344-77 with strong, bipartisan support, though opponents raise concerns about the Act’s lack of assurances of patient safety. The purpose of this legislation is to reduce the bottlenecks in the regulatory process that allow the development of new drugs. The Act would trim regulations by allowing for shorter clinical studies involving fewer individuals for certain kinds of drugs. It would also allow for expanded use of surrogate endpoints as evidence of the efficacy of drugs. Surrogate endpoints are biomarkers which are thought to predict clinical benefit, but are not outright measures of such benefit. Case studies, patient registries and existing health care data can also be utilized to speed up clinical trial endpoints. Opponents of the Act have expressed concerns that these reforms will compromise patient safety.

The fate of the bill currently rests with the Senate.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Rise in Fatty Liver Disease Linked to Obesity and Diabetes

Gut has published population results from NHANES population study showing that the prevalence of fatty liver disease is rising in the US and is driven by obesity and diabetes.

Employed Physicians Outnumber Self-Employed

For the first time in the United States, employed physicians outnumber self-employed physicians, according to a newly updated study on physician practice arrangements by the American Medical Association (AMA). This milestone marks the continuation of a long-term trend that has slowly shifted the distribution of physicians away from ownership of private practices.

 

Dr. Harold E. Paulus (1929-2019)

Dr. Harold “Hal” Paulus lives in the annals of Rheumatology as a major contributor, mentor, researcher and clinical trialist. He passed away last week, one day after his 89th birthday. I met Dr. Paulus as a fellow in 1985, when he easily included me in his discussions and research on rheumatoid arthritis. I admired his easy demeanor, wry humor and every man character. Most remark on his calm recessive and kind personality that was complemented by a body of work that was large, impactful and usually at the cutting edge. Many of Dr. Paulus’ colleagues and friends have contributed their testimonies and fond memories of this great man.

RheumNowLive On Demand: The History of Steroids - Dr. Eric Matteson

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

Mourning the Loss of NIAMS Director Stephen Katz, MD, PhD

The following tribute to the late Dr. Steven Katz appeared on the NIH website.